[1] House SJ, Potier M, Bisaillon J, et al. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch. 2008;456(5): 769-790.[2] Nilius B, Szallasi A. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol Rev. 2014;66:676-682. [3] Cosens DJ, Manning A. Abnormal electroretinogram from a drosophila mutant. Nature. 1969;224(5216):285-293. [4] Petersen CC, Berridge MJ, Borgese MF, et al. Putative capacitative calcium entry channels: expression of Drosophila trp and evidence for the existence of vertebrate homologues. Biochem J. 1995;311(Pt1):41-53. [5] Alonsocarbajo L, Kecskes M, Jacobs G, et al. Muscling in on TRP channels in vascular smooth muscle cells and cardiomyocytes. Cell Calcium. 2017;66:48-61. [6] Vazquez G, Wedel B J, Aziz O, et al. The mammalian TRPC cation channels. Biochim Biophys Acta. 2004;1742(3):21-36. [7] Trebak M, Lemonnier L, Smyth J T, et al. Phospholipase C-coupled receptors and activation of TRPC channels. Handb Exp Pharmacol. 2007;179(179):593-614. [8] Trebak M, Vazquez G, Bird GS, et al. The TRPC3/6/7 subfamily of cation channels. Cell Calcium. 2003;33(5-6): 451-466. [9] Clapham DE, Julius D, Montell C, et al. International union of pharmacology. XLIX. nomenclature and structure-function relationships of transient receptor potential channels. Pharmacol Rev. 2005;57(4):427-450. [10] Sakura H, Ashcroft FM. Identification of four trp1 gene variants murine pancreatic beta-cells. Diabetologia. 1997; 40(5): 528-537. [11] Ong EC, Nesin V, Long CL, et al. A TRPC1 protein-dependent pathway regulates osteoclast formation and function. J Biol Chem. 2013;288(31):22219-22245. [12] Rychkov G, Barritt GJ. TRPC1 Ca2+-permeable channels in animal cells. Handb Exp Pharmacol. 2007;179(179):23-47. [13] Nilius B, Flockerzi V. Mammalian Transient Receptor Potential (TRP) Cation Channels. Springer Berlin Heidelberg. 2014:105-117. [14] 崔媛媛,史娟.在神经系统中TRPC1的研究进展[J].生理科学进展,2017,48(6):58-67.[15] Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3):767-801. [16] Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83(4): 1325-1355. [17] Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ Res. 2005;96(3):280-301.[18] Rzucidlo EM, Martin KA, Powell RJ. Regulation of vascular smooth muscle cell differentiation. J Vasc Surg. 2007;45 Suppl A(6):25-38. [19] Inoue R, Jensen LJ, Shi J, et al. Transient receptor potential channels in cardiovascular function and disease. Circ Res. 2006;99(2):119-136. [20] Xu SZ, Beech DJ. TrpC1 is a membrane-spanning subunit of store-operated Ca2+ channels in native vascular smooth muscle cells. Circ Res. 2001;88(1):84-97. [21] Beech DJ. TRPC1: store-operated channel and more. Pflügers Archiv. 2005;451(1):53-60. [22] Ahmad AA, Streiff M, Hunter C, et al. Physiological and pathophysiological role of transient receptor potential canonical channels in cardiac myocytes. Prog Biophys Mol Biol. 130:254-263. [23] Trebak M. Canonical transient receptor potential channels in disease: targets for novel drug therapy? Drug Discov Today. 2006;11(19-20):924-930. [24] Dietrich A, Chubanov V, Kalwa H, et al. Cation channels of the transient receptor potential superfamily: their role in physiological and pathophysiological processes of smooth muscle cells. Pharmacol Ther. 2006;112(3):744-760. [25] Watanabe H, Murakami M, Ohba T, et al. TRP channel and cardiovascular disease. Pharmacol Ther. 2008;118(3): 337-351. [26] Kumar B, Dreja K, Shah SS, et al. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res. 2006;98(4):557-580. [27] Takahashi Y, Watanabe H, Murakami M, et al. Upregulation of TRPC1 is involved in Angiotensin II-induced vascular smooth muscle cell hypertrophy. J Mol Cell Cardiol. 2006;41(6): 1057-1057. [28] Sweeney M, Yu Y, Platoshyn O, et al. Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol. 2002;283(1):144-155. [29] Li J, Mckeown L, Ojelabi O, et al. Nanomolar potency and selectivity of a Ca2+ release-activated Ca2+ channel inhibitor against store-operated Ca2+ entry and migration of vascular smooth muscle cells. Br J Pharmacol. 2011;164(2):382. [30] Ingueneau C, Huynh-Do U, Marcheix B, et al. TRPC1 is regulated by caveolin-1 and is involved in oxidized LDL-induced apoptosis of vascular smooth muscle cells. J Cell Mol Med. 2009;13(8b):1620-1631.[31] Clapham DE. Calcium signaling. Cell. 1995;80(2):259-288. [32] Petersen OH, Michalak M, Verkhratsky A. Calcium signalling: past, present and future. Cell Calcium. 2005;38(3):161-169. [33] Michael J. Berridge. Inositol trisphosphate and calcium signalling. Nature. 1993;361(6410):315-325. [34] Putney JW. Pharmacology of store-operated calcium channels. Mol Interv. 2010;10(4):209-218. [35] Potier M, Trebak M. New developments in the signaling mechanisms of the store-operated calcium entry pathway. Pflugers Arch. 2008;457(2):405-415. [36] Putney JW Jr. Capacitative calcium entry revisited. Cell calcium. 1990;11(10):611. [37] Albert AP, Large WA. Store-operated Ca2+ -permeable non-selective cation channels in smooth muscle cells. Cell Calcium. 2003;33(5-6):345-356. [38] Takahashi Y, Watanabe H, Murakami M, et al. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis. 2007;195(2):287-296. [39] Brueggemann LI, Markun DR, Henderson KK, et al. Pharmacological and electrophysiological characterization of store-operated currents and capacitative Ca2+ entry in vascular smooth muscle cells. J Pharmacol Exp Ther. 2006; 317(2):488-499. [40] Guo R, Yang L, Li M, et al. Stim1- and Orai1-mediated store-operated calcium entry is critical for angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc Res. 2012;93(2):360-370. [41] Zhang Y, Lu W, Yang K, et al. Bone morphogenetic protein 2 decreases TRPC expression, store-operated Ca2+ entry, and basal [Ca2+]i in rat distal pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol. 2013;304(9):C833-C843. [42] Wang Y, Wang Y, Li GR. TRPC1/TRPC3 channels mediate lysophosphatidylcholine-induced apoptosis in cultured human coronary artery smooth muscles cells. Oncotarget. 2016;7(32): 50937-50951. [43] Shi J, Ju M, Abramowitz J, et al. TRPC1 proteins confer PKC and phosphoinositol activation on native heteromeric TRPC1/C5 channels in vascular smooth muscle: comparative study of wild-type and TRPC1-/- mice. FASEB J. 2012;26(1): 409-419. [44] Bird GS, Dehaven WI, Smyth JT, et al. Methods for studying store-operated calcium entry. Methods. 2008;46(3):204-212. [45] Trebak M, Bird GSJ, Mckay RR, et al. Comparison of human TRPC3 channels in receptor-activated and store-operated modes differential sensitivity to channel blockers suggests fundamental differences in channel composition. J Biol Chem. 2002;277(24):21617-21623. |